Press "Enter" to skip to content

U.S. FDA approves Catalyst Pharma’s rare disease drug

The U.S. Food and Drug Administration approved on Wednesday Catalyst Pharmaceuticals Inc’s drug to treat a rare autoimmune disease.

Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/4Y022DslfZ0/u-s-fda-approves-catalyst-pharmas-rare-disease-drug-idINKCN1NX2ZL

Also Read:   Hyderabad’s Gland Pharma to make 252 million doses of Sputnik V